德国拜耳利伐沙班的效果如何
Rivaroxaban is a highly selective, oral drug that directly inhibits factor xa. Rivaroxaban can interrupt the intrinsic and extrinsic pathways of the coagulation cascade by inhibiting factor xa, inhibiting thrombin generation and thrombosis. Rivaroxaban is clinically indicated for the prevention of venous thrombosis (VTE) in adult patients undergoing elective hip or knee replacement surgery.
Bayer is headquartered in Leverkusen, Germany. Polymers, pharmaceuticals and health care, chemicals and agriculture are the company's four pillar industries. The company's product categories exceed 10,000 types. The company has produced aspirin, heroin, Rivaroxaban and other products.
How effective is Germany's Bayer Rivaroxaban?
The RECORD1-2 study evaluated the safety and effectiveness of rivaroxaban in preventing venous thromboembolism in patients undergoing elective total hip arthroplasty.
The results showed that compared with enoxaparin, Rivaroxaban could significantly reduce the incidence of total VTE, major VTE and symptomatic VTE, while the incidence of major bleeding events and other bleeding events was similar in the two groups. The RECORD3~4 study compared the safety and effectiveness of the above two drugs in preventing venous thromboembolism in patients after elective total knee replacement. The incidence rate of the primary endpoint event in the enoxaparin group was 18.9%, while that of Rivaroxaban was only 9.6%. The difference between the two was statistically significant.
Rivaroxaban has a remarkable therapeutic effect, but treatment with Rivaroxaban will also produce certain side effects or adverse reactions, including: dizziness/insomnia/anxiety/depression/fatigue/syncope/wound secretions/itching/skin blisters/abdominal pain/heavy bleeding/increased serum aminotransferases/back pain/limb pain/muscle spasm/bronchiectasis/pulmonary bleeding, etc. Therefore, patients should not blindly use rivaroxaban for treatment.
The above is the introduction about Rivaroxaban. If patients have other questions about rivaroxaban (such as drug prices, purchase channels, etc.), they can consult the medical companion travel service.
Recommended related hot articles: /newsDetail/89996.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)